Loading...
XTAE
NRGN
Market cap10mUSD
Jul 28, Last price  
267.90ILS
1D
0.00%
1Q
1.17%
IPO
-91.06%
Name

Nrgene Technologies Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
812.55
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.49%
Rev. gr., 5y
-29.87%
Revenues
1m
-35.53%
7,313,0007,607,0007,035,0004,463,0003,159,0002,001,0001,290,000
Net income
-3m
L-35.93%
-4,494,000-3,911,000-3,146,000-8,338,000-6,207,000-5,243,000-3,359,000
CFO
-4m
L-8.80%
-839,000-3,578,000-1,423,000-5,567,000-6,118,000-3,908,000-3,564,000

Profile

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
URL
https://www.nrgene.com/
IPO date
Jan 28, 2021
Employees
55
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
1,290
-35.53%
2,001
-36.66%
3,159
-29.22%
Cost of revenue
3,663
4,344
5,085
Unusual Expense (Income)
NOPBT
(2,373)
(2,343)
(1,926)
NOPBT Margin
Operating Taxes
(8)
13
(6)
Tax Rate
NOPAT
(2,365)
(2,356)
(1,920)
Net income
(3,359)
-35.93%
(5,243)
-15.53%
(6,207)
-25.56%
Dividends
Dividend yield
Proceeds from repurchase of equity
30
BB yield
-0.05%
Debt
Debt current
219
256
321
Long-term debt
357
1,338
1,261
Deferred revenue
16
129
675
Other long-term liabilities
675
Net debt
(797)
(4,856)
(10,702)
Cash flow
Cash from operating activities
(3,564)
(3,908)
(6,118)
CAPEX
(127)
(150)
(1,707)
Cash from investing activities
(1,300)
(1,275)
12,474
Cash from financing activities
(317)
(410)
(2,455)
FCF
(1,417)
(2,422)
(1,748)
Balance
Cash
1,373
6,450
12,284
Long term investments
Excess cash
1,308
6,350
12,126
Stockholders' equity
(53,271)
(49,957)
(36,599)
Invested Capital
57,581
58,097
50,999
ROIC
ROCE
EV
Common stock shares outstanding
12,559
12,544
12,458
Price
2.49
42.09%
1.75
-61.47%
4.54
-56.39%
Market cap
31,247
42.26%
21,965
-61.20%
56,609
-55.00%
EV
30,494
17,109
45,907
EBITDA
(1,720)
(1,715)
(1,441)
EV/EBITDA
Interest
46
14
139
Interest/NOPBT